THE PRESENCE OF DIAMIDINES IN MYELOMA CELLS AFTER TREATMENT WITH STILBAMIDINE AND 2-HYDROXYSTILBAMIDINE

被引:15
|
作者
SNAPPER, I
SCHNEID, B
KURNICK, N
机构
关键词
D O I
10.1159/000203568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
  • [11] THE DEVELOPMENT OF BASOPHILIC INCLUSION BODIES IN MYELOMA CELLS AFTER STILBAMIDINE TREATMENT
    SNAPPER, I
    SCHNEID, B
    ANNALS OF INTERNAL MEDICINE, 1947, 27 (04) : 541 - 547
  • [12] TOXICITY OF 2-HYDROXYSTILBAMIDINE - PROBABLE FATAL TOXIC REACTION DURING TREATMENT OF BLASTOMYCOSIS
    OBERMAN, JW
    GILBERT, EF
    ANNALS OF INTERNAL MEDICINE, 1958, 48 (06) : 1401 - 1414
  • [13] DEVELOPMENT OF INCLUSION BODIES CONTAINING RIBOSE NUCLEIC ACID IN MYELOMA CELLS AFTER INJECTIONS OF STILBAMIDINE - DETERMINATION OF STILBAMIDINE IN MYELOMA TISSUE
    SNAPPER, I
    MIRSKY, AE
    RIS, H
    SCHNEID, B
    ROSENTHAL, M
    BLOOD, 1947, 2 (04) : 311 - 322
  • [14] MEMBRANE DYNAMICS AND FUNCTIONAL EFFECTS ON MYELOMA CELLS AFTER DARATUMUMAB TREATMENT
    Yakymiv, Y.
    Faini, A. C.
    Castella, B.
    Morandi, F.
    Larocca, A.
    Oliva, S.
    Horenstein, A. L.
    Massaia, M.
    Malavasi, F.
    HAEMATOLOGICA, 2018, 103 : S66 - S66
  • [15] Induction of structural and functional effects of myeloma cells after daratumumab treatment
    Castella, Barbara
    Faini, Angelo C.
    Yakymiv, Yuliya
    Morandi, Fabio
    Larocca, Alessandra
    Oliva, Stefania
    Horenstein, Alberto L.
    Massaia, Massimo
    Malavasi, Fabio
    CANCER RESEARCH, 2018, 78 (13)
  • [16] Immunocytochemical detection of selected proteins in myeloma cells after their treatment with epigenetic modulators
    Luzna, P.
    Cizkova, K.
    Kolar, Z.
    Trtkova, K. Smesny
    VIRCHOWS ARCHIV, 2019, 475 : S102 - S102
  • [17] Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells
    Yan, Lingzhi
    Shang, Jingjing
    Shi, Xiaolan
    Kang, Huizhu
    Liu, Wei
    Xu, Nan
    Liu, Yong
    Chen, Guanghua
    Kang, Liqing
    Gong, Feiran
    Tang, Fang
    Yu, Lei
    Wu, Depei
    Fu, Chengcheng
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (01) : E20 - +
  • [18] T-regulatory cells are reduced after treatment with lenalidomide, but not bortezomib, in multiple myeloma
    Hadjiaggelidou, C.
    Mandala, E.
    Terpos, E.
    Markala, D.
    Yiannaki, E.
    Papatheodorou, A.
    Ilonidis, G.
    Garipidou, V.
    Kaiafa, G.
    Perifanis, V.
    Vakalopoulou, S.
    Garifalos, A.
    Katodritou, E.
    ARCHIVES OF HELLENIC MEDICINE, 2016, 33 (04): : 519 - 526
  • [19] Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers
    Harisi, Revekka
    Dudas, Jozsef
    Pogany, Gabor
    Timar, Ferenc
    Olah, Julia Nagy
    Szedroi, Miklos
    Jeney, Andras
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (03) : 334 - 342
  • [20] Repopulation of osteosarcoma cells after treatment with doxorubicin in the presence of extracellular matrix biopolymers
    Revekka Harisi
    József Dudás
    Gábor Pogány
    Ferenc Timár
    Júlia Nagy Oláh
    Miklós Szendrői
    András Jeney
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 334 - 342